gabapentin
Generic: gabapentin
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
preferred pharmaceuticals inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8176
Product ID
68788-8176_e063e713-a251-45a5-8319-6458dfe33828
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075360
Listing Expiration
2026-12-31
Marketing Start
2022-04-27
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888176
Hyphenated Format
68788-8176
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA075360 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (68788-8176-1)
- 30 CAPSULE in 1 BOTTLE (68788-8176-3)
- 60 CAPSULE in 1 BOTTLE (68788-8176-6)
- 120 CAPSULE in 1 BOTTLE (68788-8176-8)
- 90 CAPSULE in 1 BOTTLE (68788-8176-9)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e063e713-a251-45a5-8319-6458dfe33828", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310430"], "spl_set_id": ["1e741495-a619-41e4-a466-0d2fb79df358"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68788-8176-1)", "package_ndc": "68788-8176-1", "marketing_start_date": "20220427"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-8176-3)", "package_ndc": "68788-8176-3", "marketing_start_date": "20220427"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (68788-8176-6)", "package_ndc": "68788-8176-6", "marketing_start_date": "20220427"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (68788-8176-8)", "package_ndc": "68788-8176-8", "marketing_start_date": "20220427"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (68788-8176-9)", "package_ndc": "68788-8176-9", "marketing_start_date": "20220427"}], "brand_name": "GABAPENTIN", "product_id": "68788-8176_e063e713-a251-45a5-8319-6458dfe33828", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-8176", "generic_name": "GABAPENTIN", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "100 mg/1"}], "application_number": "ANDA075360", "marketing_category": "ANDA", "marketing_start_date": "20220427", "listing_expiration_date": "20261231"}